Last reviewed · How we verify

NCT07513701: MRI exercise

Enhancing Physical Reserve to Promote Resilience in Physically Frail Older Adults

Recruiting now NA Last updated 7 April 2026
What this trial tests

NA trial testing Aerobic and resistance training in Frailty at Older Adults in 224 participants. Currently enrolling.

Timeline
19 January 2026
Primary endpoint
31 December 2028
31 March 2029

Quick facts

Lead sponsorThe Hong Kong Polytechnic University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment224
Start date19 January 2026
Primary completion31 December 2028
Estimated completion31 March 2029
Sites1 location across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

The Hong Kong Polytechnic University

Who can join

Adults 60 to 90, any sex, with Frailty at Older Adults. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to assess the efficacy of combined aerobic and resistance training in enhancing physical reserve in older adults with physical frailty. Investigator contend that enhanced physical reserve will enable preservation of cognitive and physical function. The main questions aims to answer are: (1) Compared with usual care (i.e., CON), will 3-month aerobic and resistance training (ATRT) improve physical reserve in older adults with physical frailty? (2) Compared with CON, will ATRT lead to changes in the neural network organization? (3) Will improved physical reserve lead to better maintenance of cognitive and physical functioning in spite of presence of white matter hyperintensities (WMH)?

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Frailty at Older Adults

Currently open trials in the same condition.

Other The Hong Kong Polytechnic University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07513701.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing